| Title |
Biopharmaceutical benchmarks 2018
|
|---|---|
| Published in |
Nature Biotechnology, December 2018
|
| DOI | 10.1038/nbt.4305 |
| Pubmed ID | |
| Authors |
Gary Walsh |
X Demographics
The data shown below were collected from the profiles of 78 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 20 | 26% |
| France | 4 | 5% |
| Switzerland | 3 | 4% |
| United Kingdom | 3 | 4% |
| Netherlands | 3 | 4% |
| Mexico | 2 | 3% |
| Spain | 2 | 3% |
| Canada | 2 | 3% |
| Norway | 2 | 3% |
| Other | 13 | 17% |
| Unknown | 24 | 31% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 59 | 76% |
| Scientists | 16 | 21% |
| Science communicators (journalists, bloggers, editors) | 2 | 3% |
| Practitioners (doctors, other healthcare professionals) | 1 | 1% |
Mendeley readers
The data shown below were compiled from readership statistics for 1,501 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 4 | <1% |
| Netherlands | 1 | <1% |
| Austria | 1 | <1% |
| Switzerland | 1 | <1% |
| Sweden | 1 | <1% |
| Brazil | 1 | <1% |
| China | 1 | <1% |
| United Kingdom | 1 | <1% |
| Unknown | 1490 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 290 | 19% |
| Student > Master | 216 | 14% |
| Student > Bachelor | 186 | 12% |
| Researcher | 167 | 11% |
| Student > Doctoral Student | 64 | 4% |
| Other | 154 | 10% |
| Unknown | 424 | 28% |
| Readers by discipline | Count | As % |
|---|---|---|
| Biochemistry, Genetics and Molecular Biology | 352 | 23% |
| Agricultural and Biological Sciences | 186 | 12% |
| Chemical Engineering | 107 | 7% |
| Pharmacology, Toxicology and Pharmaceutical Science | 96 | 6% |
| Engineering | 84 | 6% |
| Other | 201 | 13% |
| Unknown | 475 | 32% |
Attention Score in Context
This research output has an Altmetric Attention Score of 66. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 December 2022.
All research outputs
#671,093
of 25,916,093 outputs
Outputs from Nature Biotechnology
#1,383
of 8,640 outputs
Outputs of similar age
#14,748
of 448,314 outputs
Outputs of similar age from Nature Biotechnology
#25
of 81 outputs
Altmetric has tracked 25,916,093 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,640 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 44.6. This one has done well, scoring higher than 83% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 448,314 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 81 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 69% of its contemporaries.